Exjade
Drug
Novartis Pharma AG
Total Payments
$12,632
Transactions
2
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $12,632 | 2 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $9,632 | 1 | 76.3% |
| Consulting Fee | $3,000 | 1 | 23.7% |
Top Doctors Receiving Payments for Exjade
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Hematology & Oncology | Bethesda, MD | $12,632 | 2 |
Ad
Manufacturing Companies
- Novartis Pharma AG $12,632
Product Information
- Type Drug
- Total Payments $12,632
- Total Doctors 1
- Transactions 2
About Exjade
Exjade is a drug associated with $12,632 in payments to 1 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2017. In 2017, $12,632 was paid across 2 transactions to 1 doctors.
The most common payment nature for Exjade is "Travel and Lodging" ($9,632, 76.3% of total).